Loading…

Proteolysis of the low‐density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases

Bone morphogenetic protein 1 (BMP1), a member of the astacin family of zinc‐metalloproteases, proteolytically cleaves the low‐density lipoprotein receptor (LDLR) within its ligand‐binding domain, reducing the binding and cellular uptake of LDL‐cholesterol. Here, we aimed to determine whether astacin...

Full description

Saved in:
Bibliographic Details
Published in:FEBS letters 2023-06, Vol.597 (11), p.1489-1502
Main Authors: Kellett, Katherine A. B., Fisher, Kate, Aldworth, Harry, Hooper, Nigel M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4417-2f51c0657113dc018a2cc0065f8d7ce303d4bcf07d82a685449dca23bcec66133
cites cdi_FETCH-LOGICAL-c4417-2f51c0657113dc018a2cc0065f8d7ce303d4bcf07d82a685449dca23bcec66133
container_end_page 1502
container_issue 11
container_start_page 1489
container_title FEBS letters
container_volume 597
creator Kellett, Katherine A. B.
Fisher, Kate
Aldworth, Harry
Hooper, Nigel M.
description Bone morphogenetic protein 1 (BMP1), a member of the astacin family of zinc‐metalloproteases, proteolytically cleaves the low‐density lipoprotein receptor (LDLR) within its ligand‐binding domain, reducing the binding and cellular uptake of LDL‐cholesterol. Here, we aimed to determine whether astacin proteases other than BMP1 may also cleave LDLR. Although human hepatocytes express all six astacin proteases, including the meprins and mammalian tolloid, we found through pharmacological inhibition and genetic knockdown that only BMP1 contributed to the cleavage of LDLR in its ligand‐binding domain. We also found that the minimum amino acid change required to render mouse LDLR susceptible to cleavage by BMP1 is mutation at the P1′ and P2 positions of the cleavage site. When expressed in cells, the resulting humanised‐mouse LDLR internalised LDL‐cholesterol. This work provides insight into the biological mechanisms regulating LDLR function. The low‐density lipoprotein receptor (LDLR) binds LDL‐cholesterol at the cell surface and internalises. The protease BMP1 cleaves LDLR in its ligand‐binding domain, preventing the binding and internalisation of LDL‐cholesterol. BMP1 is a member of the astacin family of zinc metalloproteases, however, no other astacin protease, including the meprins, is involved in cleaving LDLR in human hepatocytes.
doi_str_mv 10.1002/1873-3468.14667
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10953048</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2820025396</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4417-2f51c0657113dc018a2cc0065f8d7ce303d4bcf07d82a685449dca23bcec66133</originalsourceid><addsrcrecordid>eNqFkc1O3DAUha2qqAy06-6Ql90E_Bc7WaGCoCCBYEHXluPcdFxl4mB7iqJu-gh9xj4JDgMjumJl3-tzvnutg9BnSg4pIeyIVooXXMjqkAop1Tu02HbeowUhVBSlqvku2ovxJ8l1ResPaJcrxkvF5AL9vg0-ge-n6CL2HU5LwL1_-PfnbwtDdGnCvRv9OIvcgANYGJMPON-XMJrk7ZQg4uxdQetMghY3Ez65vqW4WSc8-DTXPlMDNjEZm41PMBMhfkQ7nekjfHo-99H387O704vi6ubb5enXq8IKQVXBupJaIktFKW9t_oJh1pLc6KpWWeCEt6KxHVFtxYysSiHq1hrGGwtWSsr5PjrecMd1k9e0MKRgej0GtzJh0t44_f_L4Jb6h_-lKalLTkSVCV-eCcHfryEmvXLRQt-bAfw6alaxnEbJa5mlRxupDT7GAN12DiV6zkzPCek5If2UWXYcvF5vq38JKQvkRvDgepje4unzsxO2IT8CWHKk9w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2820025396</pqid></control><display><type>article</type><title>Proteolysis of the low‐density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Kellett, Katherine A. B. ; Fisher, Kate ; Aldworth, Harry ; Hooper, Nigel M.</creator><creatorcontrib>Kellett, Katherine A. B. ; Fisher, Kate ; Aldworth, Harry ; Hooper, Nigel M.</creatorcontrib><description>Bone morphogenetic protein 1 (BMP1), a member of the astacin family of zinc‐metalloproteases, proteolytically cleaves the low‐density lipoprotein receptor (LDLR) within its ligand‐binding domain, reducing the binding and cellular uptake of LDL‐cholesterol. Here, we aimed to determine whether astacin proteases other than BMP1 may also cleave LDLR. Although human hepatocytes express all six astacin proteases, including the meprins and mammalian tolloid, we found through pharmacological inhibition and genetic knockdown that only BMP1 contributed to the cleavage of LDLR in its ligand‐binding domain. We also found that the minimum amino acid change required to render mouse LDLR susceptible to cleavage by BMP1 is mutation at the P1′ and P2 positions of the cleavage site. When expressed in cells, the resulting humanised‐mouse LDLR internalised LDL‐cholesterol. This work provides insight into the biological mechanisms regulating LDLR function. The low‐density lipoprotein receptor (LDLR) binds LDL‐cholesterol at the cell surface and internalises. The protease BMP1 cleaves LDLR in its ligand‐binding domain, preventing the binding and internalisation of LDL‐cholesterol. BMP1 is a member of the astacin family of zinc metalloproteases, however, no other astacin protease, including the meprins, is involved in cleaving LDLR in human hepatocytes.</description><identifier>ISSN: 0014-5793</identifier><identifier>EISSN: 1873-3468</identifier><identifier>DOI: 10.1002/1873-3468.14667</identifier><identifier>PMID: 37235726</identifier><language>eng</language><publisher>England: John Wiley and Sons Inc</publisher><subject>Animals ; astacin ; BMP1 ; Bone Morphogenetic Protein 1 - metabolism ; Cholesterol ; hepatocytes ; Hepatocytes - metabolism ; Humans ; LDL receptor ; LDL‐cholesterol ; Ligands ; Lipoproteins, LDL - metabolism ; Liver ; Mammals - metabolism ; meprin ; Metabolism ; Mice ; Peptide Hydrolases - metabolism ; protease ; Proteolysis ; Receptors, LDL - genetics ; Receptors, LDL - metabolism ; Sterols</subject><ispartof>FEBS letters, 2023-06, Vol.597 (11), p.1489-1502</ispartof><rights>2023 The Authors. published by John Wiley &amp; Sons Ltd on behalf of Federation of European Biochemical Societies.</rights><rights>2023 The Authors. FEBS Letters published by John Wiley &amp; Sons Ltd on behalf of Federation of European Biochemical Societies.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4417-2f51c0657113dc018a2cc0065f8d7ce303d4bcf07d82a685449dca23bcec66133</citedby><cites>FETCH-LOGICAL-c4417-2f51c0657113dc018a2cc0065f8d7ce303d4bcf07d82a685449dca23bcec66133</cites><orcidid>0000-0002-5811-3484</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37235726$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kellett, Katherine A. B.</creatorcontrib><creatorcontrib>Fisher, Kate</creatorcontrib><creatorcontrib>Aldworth, Harry</creatorcontrib><creatorcontrib>Hooper, Nigel M.</creatorcontrib><title>Proteolysis of the low‐density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases</title><title>FEBS letters</title><addtitle>FEBS Lett</addtitle><description>Bone morphogenetic protein 1 (BMP1), a member of the astacin family of zinc‐metalloproteases, proteolytically cleaves the low‐density lipoprotein receptor (LDLR) within its ligand‐binding domain, reducing the binding and cellular uptake of LDL‐cholesterol. Here, we aimed to determine whether astacin proteases other than BMP1 may also cleave LDLR. Although human hepatocytes express all six astacin proteases, including the meprins and mammalian tolloid, we found through pharmacological inhibition and genetic knockdown that only BMP1 contributed to the cleavage of LDLR in its ligand‐binding domain. We also found that the minimum amino acid change required to render mouse LDLR susceptible to cleavage by BMP1 is mutation at the P1′ and P2 positions of the cleavage site. When expressed in cells, the resulting humanised‐mouse LDLR internalised LDL‐cholesterol. This work provides insight into the biological mechanisms regulating LDLR function. The low‐density lipoprotein receptor (LDLR) binds LDL‐cholesterol at the cell surface and internalises. The protease BMP1 cleaves LDLR in its ligand‐binding domain, preventing the binding and internalisation of LDL‐cholesterol. BMP1 is a member of the astacin family of zinc metalloproteases, however, no other astacin protease, including the meprins, is involved in cleaving LDLR in human hepatocytes.</description><subject>Animals</subject><subject>astacin</subject><subject>BMP1</subject><subject>Bone Morphogenetic Protein 1 - metabolism</subject><subject>Cholesterol</subject><subject>hepatocytes</subject><subject>Hepatocytes - metabolism</subject><subject>Humans</subject><subject>LDL receptor</subject><subject>LDL‐cholesterol</subject><subject>Ligands</subject><subject>Lipoproteins, LDL - metabolism</subject><subject>Liver</subject><subject>Mammals - metabolism</subject><subject>meprin</subject><subject>Metabolism</subject><subject>Mice</subject><subject>Peptide Hydrolases - metabolism</subject><subject>protease</subject><subject>Proteolysis</subject><subject>Receptors, LDL - genetics</subject><subject>Receptors, LDL - metabolism</subject><subject>Sterols</subject><issn>0014-5793</issn><issn>1873-3468</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNqFkc1O3DAUha2qqAy06-6Ql90E_Bc7WaGCoCCBYEHXluPcdFxl4mB7iqJu-gh9xj4JDgMjumJl3-tzvnutg9BnSg4pIeyIVooXXMjqkAop1Tu02HbeowUhVBSlqvku2ovxJ8l1ResPaJcrxkvF5AL9vg0-ge-n6CL2HU5LwL1_-PfnbwtDdGnCvRv9OIvcgANYGJMPON-XMJrk7ZQg4uxdQetMghY3Ez65vqW4WSc8-DTXPlMDNjEZm41PMBMhfkQ7nekjfHo-99H387O704vi6ubb5enXq8IKQVXBupJaIktFKW9t_oJh1pLc6KpWWeCEt6KxHVFtxYysSiHq1hrGGwtWSsr5PjrecMd1k9e0MKRgej0GtzJh0t44_f_L4Jb6h_-lKalLTkSVCV-eCcHfryEmvXLRQt-bAfw6alaxnEbJa5mlRxupDT7GAN12DiV6zkzPCek5If2UWXYcvF5vq38JKQvkRvDgepje4unzsxO2IT8CWHKk9w</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Kellett, Katherine A. B.</creator><creator>Fisher, Kate</creator><creator>Aldworth, Harry</creator><creator>Hooper, Nigel M.</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5811-3484</orcidid></search><sort><creationdate>202306</creationdate><title>Proteolysis of the low‐density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases</title><author>Kellett, Katherine A. B. ; Fisher, Kate ; Aldworth, Harry ; Hooper, Nigel M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4417-2f51c0657113dc018a2cc0065f8d7ce303d4bcf07d82a685449dca23bcec66133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>astacin</topic><topic>BMP1</topic><topic>Bone Morphogenetic Protein 1 - metabolism</topic><topic>Cholesterol</topic><topic>hepatocytes</topic><topic>Hepatocytes - metabolism</topic><topic>Humans</topic><topic>LDL receptor</topic><topic>LDL‐cholesterol</topic><topic>Ligands</topic><topic>Lipoproteins, LDL - metabolism</topic><topic>Liver</topic><topic>Mammals - metabolism</topic><topic>meprin</topic><topic>Metabolism</topic><topic>Mice</topic><topic>Peptide Hydrolases - metabolism</topic><topic>protease</topic><topic>Proteolysis</topic><topic>Receptors, LDL - genetics</topic><topic>Receptors, LDL - metabolism</topic><topic>Sterols</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kellett, Katherine A. B.</creatorcontrib><creatorcontrib>Fisher, Kate</creatorcontrib><creatorcontrib>Aldworth, Harry</creatorcontrib><creatorcontrib>Hooper, Nigel M.</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>FEBS letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kellett, Katherine A. B.</au><au>Fisher, Kate</au><au>Aldworth, Harry</au><au>Hooper, Nigel M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Proteolysis of the low‐density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases</atitle><jtitle>FEBS letters</jtitle><addtitle>FEBS Lett</addtitle><date>2023-06</date><risdate>2023</risdate><volume>597</volume><issue>11</issue><spage>1489</spage><epage>1502</epage><pages>1489-1502</pages><issn>0014-5793</issn><eissn>1873-3468</eissn><abstract>Bone morphogenetic protein 1 (BMP1), a member of the astacin family of zinc‐metalloproteases, proteolytically cleaves the low‐density lipoprotein receptor (LDLR) within its ligand‐binding domain, reducing the binding and cellular uptake of LDL‐cholesterol. Here, we aimed to determine whether astacin proteases other than BMP1 may also cleave LDLR. Although human hepatocytes express all six astacin proteases, including the meprins and mammalian tolloid, we found through pharmacological inhibition and genetic knockdown that only BMP1 contributed to the cleavage of LDLR in its ligand‐binding domain. We also found that the minimum amino acid change required to render mouse LDLR susceptible to cleavage by BMP1 is mutation at the P1′ and P2 positions of the cleavage site. When expressed in cells, the resulting humanised‐mouse LDLR internalised LDL‐cholesterol. This work provides insight into the biological mechanisms regulating LDLR function. The low‐density lipoprotein receptor (LDLR) binds LDL‐cholesterol at the cell surface and internalises. The protease BMP1 cleaves LDLR in its ligand‐binding domain, preventing the binding and internalisation of LDL‐cholesterol. BMP1 is a member of the astacin family of zinc metalloproteases, however, no other astacin protease, including the meprins, is involved in cleaving LDLR in human hepatocytes.</abstract><cop>England</cop><pub>John Wiley and Sons Inc</pub><pmid>37235726</pmid><doi>10.1002/1873-3468.14667</doi><tpages>1502</tpages><orcidid>https://orcid.org/0000-0002-5811-3484</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-5793
ispartof FEBS letters, 2023-06, Vol.597 (11), p.1489-1502
issn 0014-5793
1873-3468
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10953048
source Wiley-Blackwell Read & Publish Collection
subjects Animals
astacin
BMP1
Bone Morphogenetic Protein 1 - metabolism
Cholesterol
hepatocytes
Hepatocytes - metabolism
Humans
LDL receptor
LDL‐cholesterol
Ligands
Lipoproteins, LDL - metabolism
Liver
Mammals - metabolism
meprin
Metabolism
Mice
Peptide Hydrolases - metabolism
protease
Proteolysis
Receptors, LDL - genetics
Receptors, LDL - metabolism
Sterols
title Proteolysis of the low‐density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T18%3A31%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Proteolysis%20of%20the%20low%E2%80%90density%20lipoprotein%20receptor%20in%20hepatocytes%20is%20mediated%20by%20BMP1%20but%20not%20by%20other%20astacin%20proteases&rft.jtitle=FEBS%20letters&rft.au=Kellett,%20Katherine%20A.%20B.&rft.date=2023-06&rft.volume=597&rft.issue=11&rft.spage=1489&rft.epage=1502&rft.pages=1489-1502&rft.issn=0014-5793&rft.eissn=1873-3468&rft_id=info:doi/10.1002/1873-3468.14667&rft_dat=%3Cproquest_pubme%3E2820025396%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4417-2f51c0657113dc018a2cc0065f8d7ce303d4bcf07d82a685449dca23bcec66133%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2820025396&rft_id=info:pmid/37235726&rfr_iscdi=true